Global Patent Index - EP 3122364 A4

EP 3122364 A4 20171025 - PROGESTERONE FORMULATIONS

Title (en)

PROGESTERONE FORMULATIONS

Title (de)

PROGESTERONFORMULIERUNGEN

Title (fr)

FORMULATIONS DE PROGESTÉRONE

Publication

EP 3122364 A4 20171025 (EN)

Application

EP 15768772 A 20150327

Priority

  • US 201461972068 P 20140328
  • US 2015023041 W 20150327

Abstract (en)

[origin: WO2015148952A1] This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters, in particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.

IPC 8 full level

A61K 31/57 (2006.01); A61K 9/48 (2006.01); A61K 47/30 (2006.01)

CPC (source: EP KR)

A61K 9/4858 (2013.01 - EP KR); A61K 9/4866 (2013.01 - EP KR); A61K 31/57 (2013.01 - EP KR); A61P 5/24 (2017.12 - EP); A61P 5/34 (2017.12 - EP); A61P 15/06 (2017.12 - EP); A61P 15/12 (2017.12 - EP)

Citation (search report)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2015148952 A1 20151001; AR 099872 A1 20160824; AU 2015237243 A1 20160929; CA 2942568 A1 20151001; EP 3122364 A1 20170201; EP 3122364 A4 20171025; IL 247828 A0 20161130; JP 2017509630 A 20170406; JP 2019206540 A 20191205; KR 20160137597 A 20161130; MX 2016011706 A 20170501; RU 2016136666 A 20180503; RU 2016136666 A3 20181107

DOCDB simple family (application)

US 2015023041 W 20150327; AR P150100920 A 20150327; AU 2015237243 A 20150327; CA 2942568 A 20150327; EP 15768772 A 20150327; IL 24782816 A 20160914; JP 2016557059 A 20150327; JP 2019126362 A 20190705; KR 20167029519 A 20150327; MX 2016011706 A 20150327; RU 2016136666 A 20150327